Lisata Therapeutics Inc (LSTA)

[Viperciara]

Yes that is ok! I posted that same article back on July 1 Here! I think it was a very good read! jca408harvard makes a lot of sense and hopefully he is right! I hope people that did not read it then read it now! The whole post is post 2203, I included the second day post of his that says how we will get to $10 by June 2016, here is the rest of the read::

jca408harvard from yahoo CLBS Message board

The reason the stock is languishing right now is because it is currently broken. It is quite easily manipulated and leads to panic selling from longs who have already suffered significant losses. Any gains are walked back down with no catalysts in the immediate future...but CLBS is getting closer to those catalysts. The reason we didn't take a jump with the other biotechs today was because of our removal from the Russell Index. Here's how we get to $10 based on a late-July price of $2.50:

1.) CLBS10 (cardiac) partnership will happen. It is not a matter of if but when. The recent scientific advisory board is a top-notch, stellar group of cardiology experts. This is a direct preparation for partnership with application in multiple areas. This will add $2. I appreciate that Mazzo is taking his time with this to weigh all options in the partnership offers.

2.) CLBS03 (Tregs) are the platform that I am most excited about. Fantastic potential. Unfortunately, they are furthest from market right now. A partnership to begin its phase 2 trial must be near. The FDA has already approved the protocol and it doesn't do CLBS any good to have it currently not in development. This will add $2.

3.) CLBS will be cash positive by 4Q of this year. This adds $1.

4.) I am projecting 30% growth in PCT and am being conservative. This adds $1.50.

5.) I will assign a small $1 value to pure momentum of these events happening one after another.

We are clearly undervalued at this time because we have a phase 3, fully funded, fast-tracked immuno-oncology therapeutic and we are trading under $2.
We're trading at $1.87 but we are in really good shape for the future